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Biochemists often conduct experiments in-vivo in order to
explore observable behaviours and understand the
dynamics of many intercellular and intracellular proc-
esses. However an intuitive understanding of their
dynamics is hard to obtain because most pathways of
interest involve components connected via interlocking
loops. Formal methods for modelling and analysis of bio-
chemical pathways are therefore indispensable. To this
end, ODEs (ordinary differential equations) have been
widely adopted as a method to model biochemical path-
ways because they have an unambiguous mathematical
format and are amenable to rigorous quantitative analy-
sis. BioNessie http://www.bionessie.com is a workbench
for the composition, simulation and analysis of biochem-
ical networks which is being developed in by the Systems
Biology team at the Bioinformatics Research Centre as a
part of a large DTI funded project 'BPS: A Software Tool
for the Simulation and Analysis of Biochemical Networks'
http://www.brc.dcs.gla.ac.uk/projects/dti_beacon.
BioNessie is written in Java using NetBeans Platform
libraries that makes it platform independent. The software
employs specialised differential equations solvers for stiff
and non-stiff systems to produce model simulation traces.
BioNessie provides a user-friendly interfact that comes up
with an intuitive tree-based graphical layout, an edition
function to SBML-compatible models and feature of data
output.
cAMP is an acknowledged second messenger which is
involved in mediating the action of a wide range of proc-
esses in specific cells, for example the control of various
metabolism events, gene expression, cell growth and divi-
sion and cell apotosis, muscle contraction, secretion and
memory, for example [1]. Part of the aims of Xu's PhD
project are to use ODE modelling techniques to investi-
gate the effects of different phosphodiesterase on cAMP
degradation, functions of β-arrestin on uncoupling G-pro-
tein-coupled receptor and connections between cAMP
pathway and the ERK pathway, for which no computa-
tional model currently exists. The interaction between
these two signalling pathways is of pivotal importance
and is crucial to the understanding of cell function and
thus in developing new diagnostic methodologies and
new therapeutics. I have used the software tool Bionessie
to creat an SBML model of the cAMP signalling pathway
based on data reported by Bhalla [2]. The behavioural
dynamics of cAMP was fully examined using computa-
tional simulations in Bionessie (see figure 1), and an error
was found in cAMP-PKA module of the pathway.
The computational modelling of signalling pathways
using ODEs relies on exact values for rate constants and
initial concentrations; however, the lack of sufficient data
seriously limits the use of this approach. Thus a further
aim of Xu's project is to address this challenge by investi-
gating methods to permit users to explore the range of
possible solutions for a model by taking into account ine-
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quality constraints in order to permit an ODE solver to
operate over partial data. Towards the end, I have imple-
mented a two-point BVP (Boundary Value Problem)
solver in Matlab, for the solution of problems where only
partial data is vailable. In contrast to other BVP solvers
that require exact boundary value conditions to be pro-
vided, this solver can solve inequality constraints and plot
solutions with certain error distributions (see figure 2).
While not in a polished form, the use of the solver illus-
trates some of the theoretical and practical aspects os this
problem, and demonstrates the usability and flexibility of
the preliminary version. To summarise, the resulting
project will produce a powerful analytical tool for rapid
and extensive analysis and testing of models of biochem-
ical networks in order to provide novel hypotheses that
can then be evaluated experimentally with data generated
by Professor Houslay's wet laboratory.
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The solver is based on a shooting approach and programmed in Matlab. It employs the Secant method for a root finding and en les to solve separted and Di ichlet boundary condi-tionsFigure 2
The solver is based on a shooting approach and programmed 
in Matlab. It employs the Secant method for a root finding 
and enables to solve separted and Dirichlet boundary condi-
tions. The solver can also handle inequality constraints (e.g. a 
range of values) and plot solutions with certain error distri-
butions.
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cAMP pathway is a good example of signal amplification: one 
hormone molecule can lead to formation of many cAMP mol-
ecules. Low levels of cAMP allow large fractional increase 
and decrease in the concentration of cAMP with small 
amounts of cAMP made or broken down, so that the activa-
tion and deactivation can be rapid. As depicted here, cAMP 
increases to the peak soon as it is activated and then 
degraded dramatically at around 10 seconds. The figure was 
produced with the BioNessie.Page 2 of 2
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